COVID-19 Transmission 'Plausible' on Surfaces, in the Air
share to facebook share to twitter share to linkedin email article Pause Mute Remaining Time -3:44 Fullscreen The virus responsible for COVID-19 coronavirus infection is stable for several hours up through several days both in the air and on a variety of surfaces, researchers found.Source: MedPage Today
Since 1990s, Heart Attacks Have Become Less Deadly and Frequent for Americans
Heart attack prevention and outcomes have dramatically improved for American adults in the past two decades, according to a Yale study in JAMA Network Open. Compared to the mid-1990s, Americans today are less likely to have heart attacks and also less likely to die from them, said the researchers.
Krystal and Nunez-Smith Are Honored by Association for Clinical and Translational Science
John H. Krystal, MD, Robert L. McNeil, Jr. Professor of Translational Research, chair and professor of psychiatry, and professor of neuroscience; and Marcella Nunez-Smith, MD, MHS, associate professor of medicine (general medicine) and of epidemiology (chronic diseases), have been chosen for awards by the Association for Clinical and Translational Science.
CERSI Obtains FDA Grant Renewal
Joseph S. Ross, MD, MHS, associate professor of medicine (general medicine) and public health (health policy and management) was awarded a U.S. Food & Drug Administration (FDA) grant renewal up to $20M for work on the Yale-Mayo Clinic FDA Center of Excellence in Regulatory Science and Innovation (CERSI). The grant was recently renewed for years three through seven.
Improving the World’s Largest Health System—Scholars Convene at YSPH to Plan for Future
Some 200 researchers and health leaders gathered at Yale University for the second biennial conference of the China Health Policy and Management Society (CHPAMS), focusing on the Healthy China 2030 national blueprint for the health of the 1.3 billion Chinese.
Experts Convene to Discuss Improving Reproducible Research Practices for Schools of Public Health
It is estimated that more than $200 billion is spent on biomedical research every year. The return on that investment is too low, agree a group of experts who gathered at the Yale School of Public Health to discuss reproducibility and transparency in research last week.
Breast cancer care in U.S. territories lags behind care in states
Older women residing in the U.S territories are less likely to receive recommended or timely care for breast cancer compared with similar women residing in the continental United States, according to Yale researchers. Their findings were published in the March issue of Health Affairs.
China’s out of control ‘silent killer’ affects one-third of adults
More than one-third of adults in China have high blood pressure — often dubbed the “silent killer” for its lack of symptoms — but only about one in 20 have the condition under control. These findings are published Oct. 25 in the Lancet’s special issue on China by researchers at Yale and the Chinese National Center for Cardiovascular Disease.
Yale experts selected to conduct medical device surveillance research
Two projects conducted by Yale School of Medicine faculty have been selected as Demonstration Projects by NEST, the National Evaluation System for Health Technology, which was established by the Medical Device Innovation Consortium and funded by FDA.
More than 8 million children could face higher insurance costs without CHIP
More than 8 million children enrolled in the Children’s Health Insurance Program (CHIP) could be at risk of losing coverage if federal funding for the program is not extended this year. Children with chronic conditions are most vulnerable, and their families could face substantial cost increases if they lose CHIP coverage and need to shift their insurance to a Marketplace plan, according to a Yale study.
Yale Study Published in JNCCN Uncovers Racial Disparities in Treatment of Women with Breast Cancer
In a simple definition, cancer is a disease of the cells, which is caused by gene mutations. For a proportion of patients, including women with hormone receptor positive (HR+) breast cancer, gene expression profiling has a substantial impact on treatment decision-making by determining which patients might—or might not—respond to particular treatment options.
"Through the FDA looking glass" on March 7
The Yale Journal of Biology and Medicine Colloquium will host Joseph Ross, MD, MHS, associate professor of medicine and public health on Tuesday, March 7, from 12:00-1:00 pm in BCMM 206/208 (295 Congress Ave, Second Floor). He will speak about the regulatory aspects of drug development in a talk titled "Through the FDA looking glass, and what can be found there." Refreshments will be provided.
Breast MRI may lead to overdiagnosis for older women
Magnetic resonance imaging (MRI) of the breast has become part of routine medical care for many women undergoing breast cancer surgery, but these highly sensitive tests might identify health problems that would not otherwise impact patients — or lead to “overdiagnosis,” according to a Yale School of Medicine study.
Yale psychologist: How to cope in a world of climate disasters, trauma and anxiety
Climate change anxiety results in intense emotions that are valid. Dr. Sarah Lowe, clinical psychologist and Assistant Professor in the Department of Social and Behavioral Sciences at Yale School of Public Health, shares advice for when to recognize that anxiety has become problematic.Source: CNBC
Environmental Justice Conference Explores a Just Recovery
The Global Environmental Justice Conference, organized by the Yale Center on Environmental Justice and co-sponsored by the Yale Sustainable Food Program and the Center on Climate Change and Health at the Yale School of Public Health, brought together scholars, practitioners, and activists from around the world and across disciplines to discuss how scholarship, social justice, and environmental management can be effectively integrated.